In the next Cancer Matters podcast, Dr Bill Nelson speaks with Dr B Douglas Smith about treating leukemia patients with targeted therapies that reduce toxicities while also improving outcomes.
It's been a game-changing year in cancer research. Doctors and scientists don't typically like to use those words, but here's why I think this is a turning point. Scientists are churning out the genetic code of cancer cells as quickly as the cost of sequencing technology plummets. Teams of researchers are looking for ways to add the new armory of cancer cell-targeted […]
Dec 21, 2011 2 comments